My preference within this genre would be for something with more leverage and greater expected impact at the expense of local linearity. I’d especially call out the Center for Global Development, which has a history of policy wins that I think justify its budget many times over, and Target Malaria for work getting gene drives deployed to eliminate vector-borne diseases such as malaria. I’d prefer one dollar to these over multiple dollars to AMF, or the recommendations in the report.
Thanks for your feedback Carl, and for the links to the Open Phil reports on Center for Global Development and Target Malaria. I will check them out. One thing I have to keep in mind though is the donor’s preferences/mandate. While these are somewhat fuzzy/open-ended, they did not seem very interested in policy advocacy or interventions where there isn’t yet clear evidence of impact.
My preference within this genre would be for something with more leverage and greater expected impact at the expense of local linearity. I’d especially call out the Center for Global Development, which has a history of policy wins that I think justify its budget many times over, and Target Malaria for work getting gene drives deployed to eliminate vector-borne diseases such as malaria. I’d prefer one dollar to these over multiple dollars to AMF, or the recommendations in the report.
Thanks for your feedback Carl, and for the links to the Open Phil reports on Center for Global Development and Target Malaria. I will check them out. One thing I have to keep in mind though is the donor’s preferences/mandate. While these are somewhat fuzzy/open-ended, they did not seem very interested in policy advocacy or interventions where there isn’t yet clear evidence of impact.